Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec:10:100200.
doi: 10.1016/j.pvr.2020.100200. Epub 2020 May 31.

Multiple HPV infections among men who have sex with men engaged in anal cancer screening in Abuja, Nigeria

Collaborators, Affiliations

Multiple HPV infections among men who have sex with men engaged in anal cancer screening in Abuja, Nigeria

Rebecca G Nowak et al. Papillomavirus Res. 2020 Dec.

Abstract

Background: Anal precancers and cancers can be detected during screening with high-resolution anoscopy (HRA). The sensitivity of HRA depends on the burden and duration of human papillomavirus (HPV) among those screened as well as anoscopist proficiency, which is highly correlated with prior screening experience. Our objective was to compare the identification and type of HPV and the likelihood of HRA-detected precancer for men who have sex with men (MSM) undergoing their first HRA-screening in Nigeria.

Methods: MSM were recruited from an HIV test-and-treat cohort, TRUST/RV368, into a new anal cancer screening program. Anal swabs obtained during screening underwent Ion Torrent next-generation sequencing using barcoded HPV PCR broad-spectrum primers 5+/6+ to detect up to 161 HPVs. All high-risk (HR) HPVs and the most abundant low-risk (LR)-HPVs were evaluated as type-specific infections with some categorized as belonging to a multiple infection. HRA screening results included benign, low-grade squamous intraepithelial lesions (LSIL), or HSIL as detected by cytology or histology. Multivariable logistic regression was used to assess the association of HPV and other cofactors with any SIL.

Results: Among 342 MSM, 60% were HIV-infected, 89% were under 35 years of age, and 51% had 8 or more years since anal coital debut. Of those with SIL, 89% had LSIL and only 11% had HSIL. Prevalence of any HPV and high-risk (HR)-HPV was 92% and 74%, respectively. The most prevalent genotypes in rank order were HPV6 (31%), HPV16 (23%), HPV42 (20%), HPV11 (18%), HPV45 (18%), and HPV51 (17%). For multiple HR-HPVs, 31% had a single HR-HPV, 32% had 2-3, and 10% had 4 or more. Low-risk HPVs, type 6 and/or 11, were common (42%) and were significantly associated with SIL (adjusted odds ratio [aOR]:1.8, 95% confidence interval [CI]: 1.1-3.1) together with perianal warts (aOR:6.7, 95% CI: 3.3-13.5). In contrast, HR-HPV and multiple HR-HPVs were not significantly associated with SIL (all p > 0.05).

Conclusions: Detection of HSIL was low. Although HR-HPV was abundant, HSIL development also depends on the duration of HR-HPV infections and the anoscopist's level of experience. As our cohort ages and the anoscopist becomes more skilled, detection of HSIL will likely improve.

Keywords: Anal cancer screening; HPV in MSM; Next-generation sequencing; Sub-Saharan Africa.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: JMP has stock and ownership interests in Ubiome, Virion Therapeutics, VIR Biotechnology; has received honoraria from Janssen Pharmaceuticals, Vaccitech, Antiva Biosciences; has a consulting or advisory role for Antiva Biosciences, VIR Biotechnology, Vaccitech and Novan; receives research funding from Merck, Antiva Biosciences, VIR Biotechnology, CEL-SCI; and receives travel, accommodations and expenses from Merck, Vaccitech and Janssen. None of this relates to this specific work. All other authors have no declarations of interest.

Figures

Fig. 1
Fig. 1
HPV prevalence ratios and 95% confidence intervals by HIV status.

References

    1. Machalek D.A., Poynten M., Jin F., Fairley C.K., Farnsworth A., Garland S.M., Hillman R.J., Petoumenos K., Roberts J., Tabrizi S.N., Templeton D.J., Grulich A.E. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol. 2012;13:487–500. doi: 10.1016/S1470-2045(12)70080-3. - DOI - PubMed
    1. Schim van der Loeff M.F., Mooij S.H., Richel O., de Vries H.J.C., Prins J.M. HPV and anal cancer in HIV-infected individuals: a review. Curr. HIV AIDS Rep. 2014;11:250–262. doi: 10.1007/s11904-014-0224-x. - DOI - PubMed
    1. Cachay E., Agmas W., Mathews C. Five-year cumulative incidence of invasive anal cancer among HIV-infected patients according to baseline anal cytology results: an inception cohort analysis. HIV Med. 2015;16:191–195. doi: 10.1111/hiv.12190. - DOI - PMC - PubMed
    1. Phanuphak N., Teeratakulpisarn N., Triratanachat S., Keelawat S., Pankam T., Kerr S.J., Deesua A., Tantbirojn P., Numto S., Phanuphak P., Palefsky J.M., Ananworanich J. High prevalence and incidence of high-grade anal intraepithelial neoplasia among young Thai men who have sex with men with and without HIV. AIDS. 2013;27:1753–1762. doi: 10.1097/QAD.0b013e328360a509. - DOI - PMC - PubMed
    1. Siegenbeek van Heukelom M.L., Marra E., de Vries H.J.C., Schim van der Loeff M.F., Prins J.M. Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible? AIDS. 2017;31:2295–2301. doi: 10.1097/QAD.0000000000001639. - DOI - PMC - PubMed

Publication types

MeSH terms